Kinetic modeling reveals a common death niche for newly formed and mature B cells

PLoS ONE

Volumn 5, Issue 3, 2010, Pages

  Shahaf, Gitit ^a   Cancro, Michael P ^b   Mehr, Ramit ^a  

^a BAR ILAN UNIVERSITY   (Israel)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL DEATH; CELL KINETICS; CELL LABELING; CELL LOSS; CELL MATURATION; CLONAL ANERGY; CONTROLLED STUDY; IN VIVO STUDY; LYMPHOCYTE SUBPOPULATION; MATHEMATICAL MODEL; MOUSE; NONHUMAN; SPLEEN CELL; TURNOVER TIME; ALGORITHM; ANIMAL; BIOLOGICAL MODEL; BONE MARROW CELL; CELL DIFFERENTIATION; CELL MOTION; COMPUTER SIMULATION; CYTOLOGY; KINETICS; METABOLISM; PATHOLOGY; PHENOTYPE; SPLEEN; STATISTICAL MODEL; THEORETICAL MODEL;

ALGORITHMS; ANIMALS; B-LYMPHOCYTES; BONE MARROW CELLS; CELL DEATH; CELL DIFFERENTIATION; CELL MOVEMENT; COMPUTER SIMULATION; KINETICS; MICE; MODELS, BIOLOGICAL; MODELS, STATISTICAL; MODELS, THEORETICAL; PHENOTYPE; SPLEEN;

EID: 77949669230     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009497     Document Type: Article

References (33)

1. Hardy RR, Li YS, Allman D, Asano M, Gui M, et al. (2000) B-cell commitment, development and selection. Immunol Rev 175: 23-32.
2. Osmond DG, Wherry PE, Daeron M, Gordon J (1976) Immunoglobulin-bearing cells in bone marrow of mice after prolonged treatment with anti-IgM antibodies. Nature 260: 328-329.
3. Osmond DG (1990) B cell development in the bone marrow. Semin Immunol 2: 173-180.
4. Rolink A, Melchers F (1996) B-cell development in the mouse. Immunol Lett 54: 157-161.
5. Allman D, Srivastava B, Lindsley RC (2004) Alternative routes to maturity: branch points and pathways for generating follicular and marginal zone B cells. Immunol Rev 197: 147-160.
6. Cancro MP (2004) Peripheral B-cell maturation: the intersection of selection and homeostasis. Immunol Rev 197: 89-101.
7. Martin F, Kearney JF (2002) Marginal-zone B cells. Nat Rev Immunol 2: 323-335.
8. Srivastava B, Quinn WJ, 3rd, Hazard K, Erikson J, Allman D (2005) Characterization of marginal zone B cell precursors. J Exp Med 202: 1225-1234.
9. Basten A, Brink R, Peake P, Adams E, Crosbie J, et al. (1991) Self tolerance in the B-cell repertoire. Immunol Rev 122: 5-19.
10. Goodnow CC, Crosbie J, Jorgensen H, Brink RA, Basten A (1989) Induction of self-tolerance in mature peripheral B lymphocytes. Nature 342: 385-391.
11. Metcalf ES, Klinman NR (1976) In vitro tolerance induction of neonatal murine B cells. J Exp Med 143: 1327-1340.
12. Metcalf ES, Klinman NR (1977) In vitro tolerance induction of bone marrow cells: a marker for B cell maturation. J Immunol 118: 2111-2116.
13. Nemazee DA, Burki K (1989) Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 337: 562-566.
14. Nemazee D, Buerki K (1989) Clonal deletion of autoreactive B lymphocytes in bone marrow chimeras. Proc Natl Acad Sci U S A 86: 8039-8043.
15. Nossal GJ, Pike BL (1975) Evidence for the clonal abortion theory of B-lymphocyte tolerance. J Exp Med 141: 904-917.
16. Russell DM, Dembic Z, Morahan G, Miller JF, Burki K, et al. (1991) Peripheral deletion of self-reactive B cells. Nature 354: 308-311.
17. Monroe JG, Bannish G, Fuentes-Panana EM, King LB, Sandel PC, et al. (2003) Positive and negative selection during B lymphocyte development. Immunol Res 27: 427-442.
18. Nossal GJ (1983) Cellular mechanisms of immunologic tolerance. Annu Rev Immunol 1: 33-62.
19. Allman DM, Ferguson SE, Lentz VM, Cancro MP (1993) Peripheral B cell maturation. II. Heat-stable antigen(hi) splenic B cells are an immature developmental intermediate in the production of long-lived marrow-derived B cells. J Immunol 151: 4431-4444.
20. Rolink AG, Andersson J, Melchers F (1998) Characterization of immature B cells by a novel monoclonal antibody, by turnover and by mitogen reactivity. Eur J Immunol 28: 3738-3748.
21. Fulcher DA, Basten A (1994) Reduced life span of anergic self-reactive B cells in a double-transgenic model. J Exp Med 179: 125-134.
22. Fulcher DA, Lyons AB, Korn SL, Cook MC, Koleda C, et al. (1996) The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J Exp Med 183: 2313-2328.
23. Merrell KT, Benschop RJ, Gauld SB, Aviszus K, Decote-Ricardo D, et al. (2006) Identification of Anergic B Cells within a Wild-Type Repertoire. Immunity 25: 953-962.
24. Gorfine M, Freedman L, Shahaf G, Mehr R (2003) Maximum likelihood estimator and likelihood ratio test in complex models: an application to B lymphocyte development. Bull Math Biol 65: 1131-1139.
25. Mehr R, Shahaf G, Sah A, Cancro M (2003) Asynchronous differentiation models explain bone marrow labeling kinetics and predict reflux between the pre- and immature B cell pools. Int Immunol 15: 301-312.
26. Shahaf G, Allman D, Cancro MP, Mehr R (2004) Screening of alternative models for transitional B cell maturation. Int Immunol 16: 1081-1090.
27. Shahaf G, Johnson K, Mehr R (2006) B cell development in aging mice: Lessons from mathematical modeling. Intl Immunol 18 (1): 31-39.
28. Allman D, Lindsley RC, DeMuth W, Rudd K, Shinton S, et al. (2001) Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J Immunol 167: 6834-6840.
29. Agenes F, Rosado MM, Freitas AA (1999) Independent homeostatic regulation of B cell compartments. Eur J Immunol 27: 1801-1807.
30. Rolink A, Winkler TH, Melchers F, Andersson J (2000) Precursor B cell receptor-dependent B cell proliferation and differentiation does not require the bone marrow or fetal liver environment. J Exp Med 191: 23-32.
31. Allman D, Pillai S (2008) Peripheral B cell subsets. Curr Opin Immunol 20: 149-157.
32. Cambier JC, Gauld SB, Merrell KT, Vilen BJ (2007) B-cell anergy: from transgenic models to naturally occurring anergic B cells? Nat Rev Immunol 7: 633-643.
33. Loder F, Mutschler B, Ray RJ, Paige CJ, Sideras P, et al. (1999) B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J Exp Med 190: 75-89.